Insights › IP & patents › November 19, 2026
IP & patents · Pipeline & development

Anixa Biosciences Announces Issuance of Canadian Patent Strengthening International Protection for its Ovarian Cancer Vaccine Technology

PR Newswire (Biotechnology) Published: Pipeline

New patent expands Anixa's intellectual property portfolio for its innovative ovarian cancer vaccine, complementing existing U.S. patent protection SAN JOSE, Calif., Nov. 19, 2026 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company...

Original source
Read the source — prnewswire.com ↗

We link to the original publisher. The summary above is a short guide; read the original for the full details.

More in IP & patents

See everything in IP & patents →

Look into this further

Read every record in your own language

This page shows the three newest items per field. Members see every record in the field, in 109 languages, with the search engines that work on them.

Read it all — start from $3No app-store installation. Cancel any time.